Abbott changes executive team with new CFO
Abbott (NYSE:ABT) announced today that it made a series of personnel changes, including the appointment of a new chief financial officer.
Source: massdevice.com
Stay updated with breaking news from Robert Funck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott (NYSE:ABT) announced today that it made a series of personnel changes, including the appointment of a new chief financial officer.
ABT earnings call for the period ending September 30, 2022.
U.S. medical device sales rose while baby formula and COVID-19 at-home test revenue declined.
Abbott Laboratories (NYSE:NYSE:ABT) Q3 2022 Earnings Conference Call October 19, 2022 9:00 AM ETCompany ParticipantsScott Leinenweber - Vice President, Investor Relations, Licensing and...
MedTech industry news